{"id":824995,"date":"2025-03-12T16:19:43","date_gmt":"2025-03-12T20:19:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/"},"modified":"2025-03-12T16:19:43","modified_gmt":"2025-03-12T20:19:43","slug":"harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/","title":{"rendered":"Harvard Bioscience, Inc. to Participate in Two\u00a0Investor Conferences in March 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">HOLLISTON, Mass., March  12, 2025  (GLOBE NEWSWIRE) &#8212; Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will participate in two investor conferences in March 2025:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">The 37th Annual Roth Conference is being held on March 16-18, 2025, at the Laguna Cliffs Marriott Resort in Dana Point, CA. On March 17<sup>th<\/sup>, management will host one-on-one meetings and is scheduled for a Fireside Chat on the same day starting at 10 a.m. PT (1:00 p.m. ET). The live webcast is available on HBIO\u2019s website at <a href=\"https:\/\/investor.harvardbioscience.com\/events-and-presentations\" rel=\"nofollow\" target=\"_blank\">https:\/\/investor.harvardbioscience.com\/events-and-presentations<\/a>. Investors interested in scheduling a one-on-one meeting can contact <a href=\"mailto:oneonone@roth.com\" rel=\"nofollow\" target=\"_blank\">oneonone@roth.com<\/a>.\n<\/li>\n<li style=\"text-align:justify\">The KeyBanc Capital Markets Healthcare Forum is a virtual event scheduled for March 19, 2025. Management will host one-on-one meetings and is also scheduled for a Fireside Chat with Paul Knight, KeyBanc Capital Markets, on the same day starting at 3:45 p.m. ET. The live webcast is available on HBIO\u2019s website at <a href=\"https:\/\/investor.harvardbioscience.com\/events-and-presentations\" rel=\"nofollow\" target=\"_blank\">https:\/\/investor.harvardbioscience.com\/events-and-presentations<\/a>. Investors interested in scheduling a one-on-one meeting can contact <a href=\"mailto:kbcmhealthcareconferenceteam@key.com\" rel=\"nofollow\" target=\"_blank\">kbcmhealthcareconferenceteam@key.com<\/a>.<\/li>\n<\/ul>\n<p>\n        <strong>About Harvard Bioscience, Inc.<\/strong><br \/>\n        <br \/>Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world\u2019s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world. For more information, please visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OYAKQ2wkkX6Z_gCITPNdfnyst-7aOq_7e6mc0BsuW3wURmZW9g88kDI_uoGJhjB1EVSjLXmLxNZv-SPHBk7E4cZit9h8BoJx7g3rgAVvY0Y5O9WN-mIQtqjHQ2EasTWz\" rel=\"nofollow\" target=\"_blank\"><u>www.harvardbioscience.com<\/u><\/a>\u00a0<\/p>\n<p>\n        <strong>Company Contact:<\/strong>\u00a0<br \/>Harvard Bioscience\u00a0<br \/>Jennifer Cote, Chief Financial Officer\u00a0<br \/>(508) 893-3120\u00a0<\/p>\n<p>\n        <strong>Investor\u202fContacts:<\/strong>\u00a0<br \/>Three Part Advisors\u00a0<br \/>Sandy Martin \/ Erol Girgin <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=M5RaoAOEdIxNyoPtGsGm6c59kJkNs1twKZ629hNbDBeeUi765zyqo8-_GSqWNhM-6N3vBDIFlfN_OJ9BkmRvUdS--G4hSfeiJEvZGjMDq3U=\" rel=\"nofollow\" target=\"_blank\"><u>HBIO@threepa.com<\/u><\/a>\u00a0<br \/>(214) 616-2207\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzUxMCM2ODAzNTA1IzIwMDU2NDQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Y2Y0ZmUwNjEtZDg4NC00ZWZhLTlhOTQtMjgxNDE0NWE3NTI1LTEwMTcyMTctMjAyNS0wMy0xMi1lbg==\/tiny\/Harvard-Bioscience-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) &#8212; Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will participate in two investor conferences in March 2025: The 37th Annual Roth Conference is being held on March 16-18, 2025, at the Laguna Cliffs Marriott Resort in Dana Point, CA. On March 17th, management will host one-on-one meetings and is scheduled for a Fireside Chat on the same day starting at 10 a.m. PT (1:00 p.m. ET). The live webcast is available on HBIO\u2019s website at https:\/\/investor.harvardbioscience.com\/events-and-presentations. Investors interested in scheduling a one-on-one meeting can contact oneonone@roth.com. The KeyBanc Capital Markets Healthcare Forum is a virtual event scheduled for March &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Harvard Bioscience, Inc. to Participate in Two\u00a0Investor Conferences in March 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-824995","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Harvard Bioscience, Inc. to Participate in Two\u00a0Investor Conferences in March 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Harvard Bioscience, Inc. to Participate in Two\u00a0Investor Conferences in March 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) &#8212; Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will participate in two investor conferences in March 2025: The 37th Annual Roth Conference is being held on March 16-18, 2025, at the Laguna Cliffs Marriott Resort in Dana Point, CA. On March 17th, management will host one-on-one meetings and is scheduled for a Fireside Chat on the same day starting at 10 a.m. PT (1:00 p.m. ET). The live webcast is available on HBIO\u2019s website at https:\/\/investor.harvardbioscience.com\/events-and-presentations. Investors interested in scheduling a one-on-one meeting can contact oneonone@roth.com. The KeyBanc Capital Markets Healthcare Forum is a virtual event scheduled for March &hellip; Continue reading &quot;Harvard Bioscience, Inc. to Participate in Two\u00a0Investor Conferences in March 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-12T20:19:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzUxMCM2ODAzNTA1IzIwMDU2NDQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Harvard Bioscience, Inc. to Participate in Two\u00a0Investor Conferences in March 2025\",\"datePublished\":\"2025-03-12T20:19:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\\\/\"},\"wordCount\":309,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MzUxMCM2ODAzNTA1IzIwMDU2NDQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\\\/\",\"name\":\"Harvard Bioscience, Inc. to Participate in Two\u00a0Investor Conferences in March 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MzUxMCM2ODAzNTA1IzIwMDU2NDQ=\",\"datePublished\":\"2025-03-12T20:19:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MzUxMCM2ODAzNTA1IzIwMDU2NDQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MzUxMCM2ODAzNTA1IzIwMDU2NDQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Harvard Bioscience, Inc. to Participate in Two\u00a0Investor Conferences in March 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Harvard Bioscience, Inc. to Participate in Two\u00a0Investor Conferences in March 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/","og_locale":"en_US","og_type":"article","og_title":"Harvard Bioscience, Inc. to Participate in Two\u00a0Investor Conferences in March 2025 - Market Newsdesk","og_description":"HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) &#8212; Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will participate in two investor conferences in March 2025: The 37th Annual Roth Conference is being held on March 16-18, 2025, at the Laguna Cliffs Marriott Resort in Dana Point, CA. On March 17th, management will host one-on-one meetings and is scheduled for a Fireside Chat on the same day starting at 10 a.m. PT (1:00 p.m. ET). The live webcast is available on HBIO\u2019s website at https:\/\/investor.harvardbioscience.com\/events-and-presentations. Investors interested in scheduling a one-on-one meeting can contact oneonone@roth.com. The KeyBanc Capital Markets Healthcare Forum is a virtual event scheduled for March &hellip; Continue reading \"Harvard Bioscience, Inc. to Participate in Two\u00a0Investor Conferences in March 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-12T20:19:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzUxMCM2ODAzNTA1IzIwMDU2NDQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Harvard Bioscience, Inc. to Participate in Two\u00a0Investor Conferences in March 2025","datePublished":"2025-03-12T20:19:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/"},"wordCount":309,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzUxMCM2ODAzNTA1IzIwMDU2NDQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/","name":"Harvard Bioscience, Inc. to Participate in Two\u00a0Investor Conferences in March 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzUxMCM2ODAzNTA1IzIwMDU2NDQ=","datePublished":"2025-03-12T20:19:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzUxMCM2ODAzNTA1IzIwMDU2NDQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzUxMCM2ODAzNTA1IzIwMDU2NDQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/harvard-bioscience-inc-to-participate-in-two-investor-conferences-in-march-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Harvard Bioscience, Inc. to Participate in Two\u00a0Investor Conferences in March 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/824995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=824995"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/824995\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=824995"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=824995"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=824995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}